New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 16, 2012
10:07 EDTGMCR, SDRL, GPS, OSIS, ROP, MYL, GME, RFOn The Fly: Analysts Upgrade Summary
Today's noteworthy upgrades include: Gap (GPS) upgraded to Hold from Sell at Canaccord...Regions Financial (RF) upgraded to Outperform from Neutral at RW Baird...Roper Industries (ROP) upgraded to Buy from Neutral at Citigroup...Seadrill (SDRL) upgraded to Outperform from Neutral at Credit Suisse...GameStop (GME) upgraded to Buy from Above Average at Caris...OSI Systems (OSIS) upgraded to Outperform from Perform at Oppenheimer...Green Mountain (GMCR) upgraded to Buy from Neutral at Dougherty...Mylan (MYL) upgraded to Outperform from Market Perform at Leerink.
News For GPS;RF;ROP;SDRL;GME;OSIS;GMCR;MYL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
January 15, 2015
17:06 EDTGPSGap initiated with a Market Perform at Bernstein
Subscribe for More Information
16:17 EDTGMEGameStop names Tony Bartel COO
Subscribe for More Information
14:31 EDTMYLMylan launches generic Epivir-HBV tablets
Mylan (MYL) announced the U.S. launch of its Lamivudine Tablets, 100 mg, which is the generic version of GlaxoSmithKline's (GSK) Epivir-HBV. Mylan received final approval from the U.S. FDA for its Abbreviated New Drug Application for this product, which is indicated for the treatment of chronic hepatitis B virus infection associated with evidence of hepatitis B viral replication and active liver inflammation. Lamivudine Tablets, 100 mg, had U.S. sales of approximately $18.1M for the 12 months ending September 30, 2014, according to IMS Health. Currently, Mylan has 284 ANDAs pending FDA approval representing $109.1B in annual brand sales, according to IMS Health. Forty-four of these pending ANDAs are potential first-to-file opportunities, representing $29.3B in annual brand sales, for the 12 months ending June 30, 2014, according to IMS Health.
10:37 EDTGMCRKraft rises after Goldman gets less cautious on food space, ups stock to buy
Shares of Kraft Foods (KRFT) are climbing after Goldman Sachs upgraded the stock to Buy and placed the shares on its Conviction List. WHAT'S NEW: Costs for food makers are declining as commodity prices drop, Goldman Sachs analyst Judy Hong wrote in a note to investors today. Kraft is among the U.S. food companies that benefits the most from lower costs, the analyst stated. Additionally, Kraft's pricing power is one of the strongest in the group and it is heavily exposed to the U.S. economy, the analyst stated. WHAT'S NOTABLE: Hong's upgrade of Kraft was part of a note in which she took a more balanced view of the U.S. consumer staples sector. The analyst upgraded the Food sector to Neutral from Cautious, noting that consumer staples stocks with outsized exposure to the U.S. market should be boosted by strong U.S. growth and more favorable foreign exchange dynamics than their peers. In addition to Kraft, the analyst identified the following stocks as her top picks within the consumer staples sector: Monster Beverage (MNST), Constellation Brands (STZ), Coca-Cola Enterprises (CCE), Keurig Green Mountain (GMCR), Freshpet (FRPT), Mead Johnson (MJN), and Estee Lauder (EL). Goldman also upgraded Hershey (HSY), Dr. Pepper Snapple (DPS), and Clorox (CLX), all to Neutral from Sell, downgraded cigarette maker Philip Morris (PM) to Sell from Neutral and downgraded brewer Molson Coors (TAP) to Neutral from Buy. PRICE ACTION: In early trading, Kraft climbed 3.7% to $65 per share.
10:19 EDTGMEOptions with decreasing implied volatility
Subscribe for More Information
January 14, 2015
16:33 EDTGMEOn The Fly: Closing Wrap
Subscribe for More Information
10:21 EDTGMEOptions with decreasing implied volatility
Subscribe for More Information
10:00 EDTGMEOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:16 EDTGMEOn The Fly: Pre-market Movers
HIGHER: ZIOPHARM (ZIOP), up 53% after the company and Intrexon (XON) announced a licensing agreement with University of Texas. Intrexon shares are also up 12%... GameStop (GME), up 10.6% after reporting holiday SSS, providing guidance for the fourth quarter and fiscal 2014, and being upgraded at Pacific Crest... Smith Micro (SMSI), up 12.7% after reporting preliminary fourth quarter revenue and providing revenue guidance for the first quarter and fiscal 2015... BioCryst (BCRX), up 3.2% after receiving a positive opinion on EMA orphan drug designation for BCX4161... GoPro (GPRO), up 1% following analyst remarks that sell-off after yesterday's report on Apple (AAPL) patent was "overdone." DOWN AFTER EARNINGS: JPMorgan (JPM), down 2.7%... Wells Fargo (WFC), down 2.2%... Banking peers down as well, with Bank of America (BAC) down 2.8% and Citi (C) down 2%. ALSO LOWER: Tesla (TSLA), down 9% following comments made by CEO Elon Musk at an automotive conference in Detroit regarding a slowdown in China... New Media (NEWM), down 4.8% after 7M share spot secondary priced at $21.70... General Motors (GM), down 3% after giving 2015 guidance, saying it is on track to meet previously announced 2016 financial targets... Apple (AAPL), down 1% following lawsuit against Ericsson (ERIC) and countersuit filing.
07:47 EDTGMEGameStop new software sales promising, says SunTrust
After GameStop reported roughly in-line holiday SSS but said that its new software sales had risen 6%, the firm thinks the overall holiday data bodes well for the company's Q4 results. The firm keeps a Buy rating on the shares.
07:23 EDTGMEGameStop looks to be capitalizing on new products, says Oppenheimer
After GameStop reported that its total holiday SSS fell 3.1% but reiterated its previous Q4 EPS guidance, Oppenheimer says the company looks to be capitalizing on new products, while the short thesis on the stock was "somewhat" undermined by the company's report. The firm says the company is not yet out of the woods, but keeps an Outperform rating on the shares.
06:38 EDTGMEGameStop upgraded to Outperform from Underperform at Pacific Crest
Subscribe for More Information
January 13, 2015
18:37 EDTGMEOn The Fly: After Hours Movers
Subscribe for More Information
18:24 EDTGMEGameStop now sees FY14 SSS up 3% to up 4%
18:24 EDTGMEGameStop now sees Q4 SSS down 2.5% to down 1%
Subscribe for More Information
16:18 EDTGMEGameStop trades up after hours, levels to watch
Shares are up over 6.8% to $35 in the extended session. At that price resistance is at the after hours high at $36 and then at $37.20. Support is at $34.88.
16:14 EDTGMEGameStop up 9.3% after reporting holiday SSS, backing Q4, FY14 EPS guidance
Subscribe for More Information
16:13 EDTGMEGameStop backs FY14 EPS view of $3.40-$3.55, consensus $3.49
16:13 EDTGMEGameStop backs Q4 EPS view of $2.08-$2.24, consensus $2.16
Subscribe for More Information
16:12 EDTGMEGameStop reports total holiday SSS down 3.1%
Subscribe for More Information
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use